{
  "id": 9309443,
  "title": "Will FDA advisers recommend a multi-cancer blood test for approval? They'll vote",
  "url": "https://urgent.news/2026/09/23/will-fda-advisers-recommend-a-multi-cancer-blood-test-for-approval",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-09-23T10:00:00.000Z",
  "source": {
    "name": "NPR",
    "slug": "npr",
    "url": "https://www.npr.org/2026/09/23/nx-s1-5978122/fda-blood-cancer-test-galleri"
  },
  "original_language": "en",
  "account": null,
  "summary": "The company Grail says its Galleri blood test can detect up to 50 forms of cancer. An independent panel of experts will decide if the test should be recommended for FDA approval.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 3,
    "also_reported_by": [
      {
        "outlet": "NPR Health",
        "title": "Will FDA advisers recommend a multi-cancer blood test for approval? They'll vote",
        "url": "https://urgent.news/2026/09/23/will-fda-advisers-recommend-a-multi-cancer-blood-test-for-approval-9314106",
        "published": "2026-09-23T10:00:00.000Z"
      },
      {
        "outlet": "MarketWatch Top",
        "title": "FDA advisers are reviewing a multicancer-detection test. Medicare coverage could follow.",
        "url": "https://urgent.news/2026/09/23/fda-advisers-are-reviewing-a-multicancer-detection-test-medicare",
        "published": "2026-09-23T12:39:00.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}